Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis

NCT04201886 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-12-17

No results posted yet for this study

Summary

Assessment of the serum level of calprotectin in patients with rheumatoid arthritis and osteoarthritis.

Conditions

  • Rheumatoid Arthritis and Osteoarthritis

Interventions

OTHER

serum calprotectin

serum calcium binding leucocyte protein

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mona Hussien Abd El-Samea, Dr. · Assiut university hospitals

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2020-10-31
Completion
2021-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04201886 on ClinicalTrials.gov